Z-0667-2024 Class II Ongoing

Recalled by Baxter Healthcare Corporation — Deerfield, IL

FDA device recall Z-0667-2024 was initiated by Baxter Healthcare Corporation on December 6, 2023 and is designated Class II. Reason for recall: Cardiovascular Surgery marketing brochure (US-AS46-220001) that was distributed for the products listed below contains inaccurate content that does not align with some of the products Instructions fo… The recall status is ongoing.

Recall Details

Product Type
Devices
Report Date
January 17, 2024
Initiation Date
December 6, 2023
Termination Date
N/A
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity

Product Description

Baxter FloSeal Hemostatic Matrix NL, 5 mL, Product Codes: ADS201883

Reason for Recall

Cardiovascular Surgery marketing brochure (US-AS46-220001) that was distributed for the products listed below contains inaccurate content that does not align with some of the products Instructions for Use (IFU) or Prescribing Information (PI).

Distribution Pattern

US Nationwide distribution.

Code Information

UDI/DI 85412656304, All serial numbers